How should tachycardia and increased respiratory rate during an intravenous immunoglobulin (IVIG) infusion be managed?

Management of Tachycardia and Increased Respiratory Rate During IVIG Infusion

Immediately slow or stop the IVIG infusion, maintain IV access, assess vital signs and airway/breathing/circulation, and determine whether this represents a mild infusion reaction (requiring rate reduction and symptomatic treatment) versus anaphylaxis (requiring epinephrine). 1

Initial Assessment and Differentiation

Distinguish between a mild-to-moderate infusion reaction and anaphylaxis:

• Mild infusion reaction presents with tachycardia, increased respiratory rate, fever, chills, headache, or flushing without hypotension, bronchospasm, wheezing, angioedema, or severe dyspnea 1
• Anaphylaxis includes any of: bronchospasm, dyspnea/wheezing, hypotension, angioedema, cyanosis, or life-threatening respiratory/cardiovascular compromise 1, 2
• Tachycardia and tachypnea are early warning signs of serious transfusion/infusion reactions and must be taken seriously 3

Monitor vital signs immediately: heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature 3, 1

Management Algorithm for Mild-to-Moderate Infusion Reactions (No Anaphylaxis)

Grade 1 (Mild) Reactions

• Slow the infusion rate to 0.01 mL/kg/min (0.5 mg/kg/min) 4
• Continue monitoring vital signs every 15 minutes 3, 2
• If symptoms resolve, gradually increase rate to maximum 0.10 mL/kg/min (5 mg/kg/min) as tolerated 4

Grade 2 (Moderate) Reactions

• Stop or significantly slow the infusion 1
• Maintain IV access with normal saline 1
• Administer diphenhydramine 50 mg IV (H1 antagonist) plus ranitidine 50 mg IV (H2 antagonist) 1, 2
• Consider methylprednisolone 1–2 mg/kg IV every 6 hours for moderate symptoms 1
• Once stable, restart infusion at 50% of the original rate and titrate to tolerance 1
• Monitor continuously until symptoms resolve 1

Grade 3–4 (Severe) Reactions

• Permanently stop the infusion 1
• Treat as potential anaphylaxis (see below) 1

Management of Anaphylaxis

If any criteria for anaphylaxis are met, administer epinephrine immediately:

• Epinephrine 0.2–0.5 mg IM (1 mg/mL dilution) into the lateral thigh muscle 1
• Repeat every 5–15 minutes as needed 1
• Fluid resuscitation: 1–2 liters normal saline IV at 5–10 mL/kg in the first 5 minutes 1
• Diphenhydramine 50 mg IV plus ranitidine 50 mg IV as adjunctive therapy 1, 2
• Methylprednisolone 1–2 mg/kg IV every 6 hours to prevent biphasic reactions 1
• Position patient appropriately: Trendelenburg for hypotension, sitting upright for respiratory distress 1
• Administer oxygen as needed 1

For refractory hypotension despite epinephrine and fluids:

• Dopamine 400 mg in 500 mL at 2–20 mcg/kg/min 1
• Vasopressin 25 units in 250 mL (0.1 U/mL) at 0.01–0.04 U/min 1

For bradycardia: atropine 600 mcg IV 1

For patients on beta-blockers: glucagon 1–5 mg IV over 5 minutes 1

Prevention Strategies for Future Infusions

If patient experienced a prior infusion reaction:

• Premedicate 30–60 minutes before next infusion with oral or IV antihistamine (diphenhydramine 25–50 mg or cetirizine 10 mg) 2, 5
• Consider adding corticosteroid premedication (methylprednisolone 100 mg IV) 6, 5
• Ensure adequate hydration before and during infusion 7, 8
• Start at slower infusion rate (0.01 mL/kg/min) and increase gradually only if tolerated 4, 6, 7, 8
• Avoid rapid infusion rates, which increase risk of adverse reactions 7, 8

Post-Reaction Monitoring

• Monitor vital signs continuously until all symptoms resolve 1
• Observe for at least 6 hours after mild-to-moderate reactions 2
• Observe for 24 hours after severe reactions or anaphylaxis 1
• Watch for biphasic reactions (recurrence of symptoms after initial resolution) 1

Common Pitfalls to Avoid

Do not use antihistamines as first-line treatment for anaphylaxis—epinephrine is the only appropriate initial therapy 2

Do not assume all reactions are allergic—tachycardia and tachypnea during IVIG may represent volume overload, especially in patients with cardiac or renal disease 3, 7, 8

Do not restart infusion at the same rate after a reaction—always reduce to 50% or slower 1, 4

Do not give IVIG rapidly in high-risk patients (elderly, dehydrated, renal insufficiency, diabetes, previous thromboembolic events)—slow infusion and hydration are critical 7, 8

Do not ignore mild symptoms—tachycardia and increased respiratory rate are early warning signs that may progress to severe reactions 3, 5